Bendamustine in combination with thalidomide and prednisone in patients with refractory or relapsed multiple myeloma. preliminary results of a phase I clinical trial

被引：0
|
作者：
Pönisch, W
Rozanski, M
Leiblein, S
Goldschmidt, H
Wegner, A
Niederwieser, D
机构：
[1] Univ Leipzig, Dept Haematol Oncol, D-7010 Leipzig, Germany
[2] Ribosepharm GmbH, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
584
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of melphalan, prednisone,thalidomide and defibrotide in relapsed and refractory multiple myeloma patients: Results of a multicenter phase I/II trial
    Palumbo, A.
    Larocca, A.
    Rus, C.
    Gay, E.
    Rossi, D.
    Pregno, P.
    Falco, P.
    Avonto, I.
    Magarotto, V.
    D'Agostino, F.
    Iacobelli, M.
    Gaidano, G.
    Mitsiades, C.
    Richardson, P. G.
    Anderson, K.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 94 - 94
  • [22] A MULTICENTER PHASE II CLINICAL TRIAL OF LENALIDOMIDE, MELPHALAN, PREDNISONE AND THALIDOMIDE (RMPT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Palumbo, A.
    Larocca, A.
    Sanpaolo, G.
    Falcone, A. P.
    Federico, V.
    Canepa, L.
    Crugnola, M.
    Magarotto, V.
    Cavallo, F.
    Petrucci, M. T.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 153 - 153
  • [23] A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
    Lee, Hans C.
    Shah, Jatin J.
    Feng, Lei
    Morphey, Ashley
    Johnson, Ralph J.
    Wesson, Emily T.
    Wang, Michael L.
    Alexanian, Raymond
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Weber, Donna M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : E319 - E322
  • [24] Bendamustine in combination with thalidomide and prednisolone (BPT) in patients with refractory or relapsed multiple myeloma after conventional chemotherapy: Final results of a phase I study.
    Poenisch, W
    Rozanski, M
    Leiblein, S
    Goldschmidt, H
    Hoffmann, FA
    Boldt, T
    Rohrberg, R
    Schwalbe, E
    Uhlig, J
    Niederwieser, D
    BLOOD, 2005, 106 (11) : 371B - 372B
  • [25] A phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone for relapsed/refractory multiple myeloma.
    Reece, Donna E.
    Piza, Giovanni
    Trudel, Suzanne
    Pantoja, Manela
    Chen, Christine
    Mikhael, Joseph R.
    Kukreti, Vishal
    Stewart, Keith
    BLOOD, 2006, 108 (11) : 1009A - 1009A
  • [26] Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial
    Schey, Steve
    Brown, Sarah R.
    Tillotson, Avie-Lee
    Yong, Kwee
    Williams, Cathy
    Davies, Faith
    Morgan, Gareth
    Cavenagh, Jamie
    Cook, Gordon
    Cook, Mark
    Orti, Guillermo
    Morris, Curly
    Sherratt, Debbie
    Flanagan, Louise
    Gregory, Walter
    Cavet, James
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (03) : 336 - 348
  • [27] Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial
    Kumar, Sudhir
    Sharma, Atul
    Malik, Prabhat Singh
    Gogia, Ajay
    Pathak, Neha
    Sahoo, Ranjit Kumar
    Gupta, Ritu
    Prasad, Chandra Prakash
    Kumar, Lalit
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (02) : 288 - 297
  • [28] Final Results of a Phase I/II Trial of the Combination of Concurrent Lenalidomide, Thalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Myeloma
    Shah, Jatin J.
    Orlowski, Robert Z.
    Thomas, Sheeba K.
    Alexanian, Raymond
    Wang, Michael
    Qazilbash, Muzaffar H.
    Popat, Uday R.
    Parmar, Simrit
    Shah, Nina
    Bashir, Qaiser
    Champlin, Richard E.
    Weber, Donna M.
    BLOOD, 2012, 120 (21)
  • [29] Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
    Ocio, Enrique M.
    Mateos, Maria-Victoria
    Prosper, Felipe
    Martin, Jesus
    Rocafiguera, Albert Oriol
    Jarque, Isidro
    Iglesias, Rebeca
    Motlloo, Cristina
    Sole, Maria
    Rodriguez-Otero, Paula
    Martinez, Sara
    Fernandez-Garcia, Eva
    Michot, Jean-Marie
    Soto-Matos, Arturo
    Diaz-Pavon, Jose Rodriguez
    Ribrag, Vincent
    Miguel, Jesus San
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)
    Beck, Juliane
    Schwarzer, Andreas
    Glaeser, Dietrich
    Muegge, Lars-Olof
    Uhlig, Jens
    Heyn, Simone
    Kragl, Brigitte
    Mohren, Martin
    Hoffmann, Franz Albert
    Lange, Thoralf
    Schliwa, Thomas
    Zehrfeld, Thomas
    Becker, Cornelia
    Kreibich, Ute
    Winkelmann, Cornelia
    Edelmann, Thomas
    Andrea, Marc
    Bill, Marius
    Jentzsch, Madlen
    Schwind, Sebastian
    Niederwieser, Dietger
    Poenisch, Wolfram
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (12) : 2545 - 2553
12345